Bret Jensen
Bret Jensen is the lead equities analyst with Investors Alley. He's the editor of their newsletters including The Growth Stock Advisor and Biotech Gems.
Bret Jensen's Latest Posts
4 Takeover Targets In The Market’s Hottest Sector
There has been a fast and furious resurgence in M&A in this sector with tens of billions of dollars of deals going down in just the last couple of months. With expectations that dealmaking will continue to increase, consider these four stocks as solid investments with the chance for huge returns if they are purchased […]
Top 3 Predictions For The Market In 2017
Some major themes have developed in the market this year that will carry over into 2017 and change how investors will profit in the market. Bret Jensen shares his top three strategies for which stocks will win and which will lose in 2017. The third quarter has officially wound to a close. The market has […]
Buy These 3 Stocks Insiders Love
When insiders step up and put millions of their own dollars on the line to purchase company stock, investors should take notice. Don’t wait to only then see these stocks on CNBC rocketing up double-digits, buy shares today. After over two decades of successfully investing in the volatile and lucrative small biotech space, I have […]
Sell These 5 Stocks On The Verge Of Bankruptcy
These stocks have serious red flags and are ticking time bombs in your portfolio. Several companies from our 2014 and 2015 watchlists are already bankrupt or very close, and the companies profiled today are likely on the same track. Dump these losers immediately. Bankruptcy is a scary thing but a natural part of the economic […]
2 Stocks To Profit From Apple’s iPhone 7
Apple is shaking up the tech scene with a new round of iPhones, but will it be enough to turn the tables for the faltering tech stock? Find out which two stocks will profit most from the newest release of the iPhone. Apple (NASDAQ: AAPL) has done it again, shaking up the technology field with […]
4 Undervalued Growth Stocks Deserving Your Interest
Pick up your pen and paper and write down the names of these four stocks that right now trade for valuations too low for their potential growth. With most stocks tading for premiums right now, finding four growth stocks with attractive valuations to add to your portfolio is worth your attention. I have followed and […]
Top 5 Favorite Stocks After Earnings
After reading through hundreds of earnings reports, Bret Jensen has selected his top five favorite stocks with the best prospects after second quarter earnings. If you’re looking for a short-list of a top-rated analyst’s favorite stocks, look no further. We have been in the heart of second quarter earnings season for a couple of weeks […]
7 Stocks To Buy In The Market’s Hottest Sectors
Invest in the momentum of these seven stocks spanning three different sectors that all have strong economic tailwinds lifting their revenues, profits, and stock prices higher. As the market continues to flirt with and reach new all-time highs, many sectors in the market seem primed to far outpace their peers. Sometimes being a good investor […]
Earnings Report Card: Stocks To Buy & Sell
Stocks look like they will extend their profit recession for a fifth quarter in a row, but not all stocks reported lower earnings. Bret Jensen shares which stocks and sectors that he is bullish on and those that he wants to avoid for the time being. The markets keep grinding up and hitting all-time highs […]
4 Likely Biotech Takeover Targets To Buy
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]
